Calcineurin Inhibitor (CNI)
Pregnancy: Use with specialist guidance — maintained in pregnancy in transplant patients; hypertension and preeclampsia risk
Ciclosporin
Brand names: Neoral, Sandimmun
Adult dose
Dose: Renal transplant: 10–15 mg/kg/day initially (divided BD), reduce to 2–6 mg/kg/day maintenance. Nephrotic syndrome: 2.5–5 mg/kg/day BD. Target C2 (2h post-dose) levels: 800–1400 ng/mL early post-transplant.
Route: Oral (Neoral microemulsion preferred — better bioavailability than Sandimmun)
Frequency: Twice daily
Max: Per protocol and trough/C2 levels
Neoral and Sandimmun are NOT bioequivalent — do not interchange. Consistent dosing time relative to meals essential. Avoid grapefruit.
Paediatric dose
Dose: 5 mg/kg
Route: Oral
Frequency: Twice daily (initial post-transplant: 5 mg/kg BD)
Max: Titrate to whole-blood trough or 2-hour level (C2) per transplant protocol
Concentration: 25 mg/mL oral solution; 25 mg, 50 mg, 100 mg capsules mg/ml
BNFc paediatric transplant (specialist initiation): 3–6 mg/kg orally BD initially (typically 5 mg/kg BD post-renal transplant). Trough-level or C2-level targeted. Children typically need higher mg/kg doses than adults due to faster clearance. Neoral and Sandimmun are NOT bioequivalent — do not interchange. Avoid grapefruit.
Dose adjustments
Renal
Nephrotoxic — dose adjusted to levels; avoid NSAIDs, aminoglycosides co-use
Hepatic
Extensive hepatic metabolism — reduce dose in hepatic impairment, monitor levels
Paediatric weight-based calculator
BNFc paediatric transplant (specialist initiation): 3–6 mg/kg orally BD initially (typically 5 mg/kg BD post-renal transplant). Trough-level or C2-level targeted. Children typically need higher mg/kg doses than adults due to faster clearance. Neoral and Sandimmun are NOT bioequivalent — do not interchange. Avoid grapefruit.
Clinical pearls
- C2 monitoring (2h post-dose) better than trough for therapeutic monitoring of Neoral
- Gingival hyperplasia: dental hygiene review regularly; may require azithromycin or switch to tacrolimus if severe
- Hirsutism problematic especially in women — consider switch to tacrolimus if distressing
- Grapefruit juice contraindicated — inhibits CYP3A4
Contraindications
- Concomitant tacrolimus (additive nephrotoxicity)
- Uncontrolled hypertension
- Uncontrolled infection
- Malignancy (most)
Side effects
- Nephrotoxicity
- Hypertension
- Gingival hyperplasia
- Hirsutism
- Tremor
- Hyperlipidaemia
- Hyperkalaemia
- Hypomagnesaemia
- Lymphoma risk
Interactions
- Strong CYP3A4 inhibitors — markedly increase ciclosporin levels
- Strong CYP3A4 inducers — markedly reduce levels (rifampicin, St John's Wort)
- Statin interaction — increased myopathy risk (lovastatin/simvastatin avoid; use pravastatin)
- Bosentan — contraindicated (severe increase in bosentan levels)
- NSAIDs — additive nephrotoxicity
Monitoring
- Ciclosporin levels (C0 or C2)
- Renal function (creatinine, eGFR)
- Blood pressure (frequent)
- LFTs
- Lipid profile
- Potassium and magnesium
Reference: BNFc; BNF; KDIGO Transplant Guidelines; UK Renal Association; BNF for Children. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Travis Criteria for Severe Ulcerative Colitis · Inflammatory Bowel Disease
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
Pathways
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
- Rhabdomyolysis · Renal Association 2018; UpToDate 2024
- Hypocalcaemia (Adult) · Society for Endocrinology
- SIADH (Endocrine Perspective) · European Hyponatraemia Guidelines 2014
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Acute Kidney Injury (AKI) · KDIGO 2012 / NICE AKI 2019